- Page 1 and 2:
Combined Actions and Interactions o
- Page 3 and 4:
Contents CONTENTS 3 PREFACE 6 SAMME
- Page 5 and 6:
7.2.4 Test systems 85 7.2.5 In vitr
- Page 7 and 8:
Sammenfatning og konklusioner Indle
- Page 9 and 10:
er ingen viden om, hvorledes den ko
- Page 11 and 12:
estemt biologisk respons (ED10, ED2
- Page 13 and 14:
vivo. The COMET-assay in vivo and g
- Page 15 and 16:
and antagonistic effects may be see
- Page 17 and 18:
1 Introduction Prepared by John Chr
- Page 19 and 20:
Table 1.3.1: Classification of comb
- Page 21 and 22:
Physicochemical interactions will t
- Page 23 and 24:
US EPA (1986) applied the concept o
- Page 25 and 26:
2.4 Test strategies to assess combi
- Page 27 and 28:
Figure 2.4.3.1. Isobologram of two
- Page 29 and 30:
CI = d1 /D1 = 1 In this case the is
- Page 31 and 32:
2.5 Toxicological test methods When
- Page 33 and 34:
3 General concepts in the risk asse
- Page 35 and 36:
NOAEL, this indicates that the subs
- Page 37 and 38:
of uncertainty i.e. differences in
- Page 39 and 40:
describe toxicities that appears to
- Page 41 and 42:
should be estimated for all endpoin
- Page 43 and 44:
1,2,3,6,7,8-HxCDF 0.1 1,2,3,7,8,9-H
- Page 45 and 46:
shows the pronounced influence of t
- Page 47 and 48:
Table 4.3.1 Estimates of carcinogen
- Page 49 and 50:
Figure 4.4.1.1. Scheme for safety e
- Page 51 and 52:
obvious ranking of individual const
- Page 53 and 54:
4.5 Approach for assessment of join
- Page 55 and 56:
4.6 Approaches currently used by re
- Page 57 and 58:
no internationally accepted procedu
- Page 59:
Figure 4.6.3.1 Flow chart of the ri
- Page 62 and 63:
octyltin dichloride). A number of a
- Page 64 and 65:
stannous chloride and cadmium chlor
- Page 66 and 67:
seen in the animals from the 1000x
- Page 68 and 69:
c TCTFP = 1,1,2-trichloro-3,3,3-tri
- Page 70 and 71:
6 Interactions in toxicokinetics Pr
- Page 72 and 73:
once more exposed and the kinetics
- Page 74 and 75:
Dermis The dermis consists of a sup
- Page 76 and 77:
7.1.3 Ocular irritancy 7.1.3.1 Comp
- Page 78 and 79:
Another in vitro test for ocular ir
- Page 80 and 81: lipid peroxidation was observed, wh
- Page 82 and 83: mixture. These interactions may dev
- Page 84 and 85: 0.6% of live births in humans. In s
- Page 86 and 87: DNA, and that the cell was capable
- Page 88 and 89: (Sorsa et al. 1994, Myslak & Kosmid
- Page 90 and 91: Four inhibitors of DNA topoisomeras
- Page 92 and 93: cyclophosphamide-metabolising enzym
- Page 94 and 95: Nickel compounds are carcinogenic t
- Page 96 and 97: 7.2.8 Conclusion As shown in this r
- Page 98 and 99: Since no compounds are known to cau
- Page 100 and 101: In a more mechanistic sense, promot
- Page 102 and 103: Several inhibitors of tumour promot
- Page 104 and 105: Table 7.4.1.1 Overview of in vivo t
- Page 106 and 107: analysis was used to predict the hi
- Page 108 and 109: interaction of TCDD and retinoic ac
- Page 110 and 111: and now includes compounds as diver
- Page 112 and 113: Furthermore, the estrogenic effects
- Page 114 and 115: Dose of A (arbitrary units) 10 8 6
- Page 116 and 117: chance or experimental error. One w
- Page 118 and 119: 7.6.2.3 Receptors A receptor is a b
- Page 120 and 121: 7.6.5.2 Kindling Kindling is the ph
- Page 122 and 123: Science Institute (RSI) have conven
- Page 124 and 125: eaction with sulfhydryl groups). Th
- Page 126 and 127: 7.7.1.3 Mechanisms of immunotoxicit
- Page 128 and 129: tested separately. This is a phenom
- Page 132 and 133: 8.3 Conference proceedings Proceedi
- Page 134 and 135: with combinations of environmental
- Page 136 and 137: Boyd MR, Statham CM and Longo NS (1
- Page 138 and 139: De Wall EJ, Schuurman HJ and Van Lo
- Page 140 and 141: theoretical considerations and a su
- Page 142 and 143: Groten JP, Sinkeldam EJ, Muys T, Lu
- Page 144 and 145: Howes D, Guy R, Hadgraft J, Heyling
- Page 146 and 147: cytochrome P450 1A2 expressed in Am
- Page 148 and 149: Lison D, Carbonnelle P, Mollo L, La
- Page 150 and 151: Narotsky MG, Weller EA, Chinchilli
- Page 152 and 153: Ramsey JC and Andersen ME (1984). A
- Page 154 and 155: Silva E, Rajapakse N and Kortenkamp
- Page 156 and 157: Leeuwen FXR, Liem AKD, Nolt C, Pete
- Page 158: Wlodarczyk B, Biernacki B, Minta M,